Dlugosz Angelika, Janecka Anna
Department of Biomolecular Chemistry, Medical University of Lodz, Mazowiecka 6/8, 92-215 Lodz, Poland.
Curr Pharm Des. 2016;22(30):4705-4716. doi: 10.2174/1381612822666160302103646.
Cancer is one of the leading causes of mortality in the developed countries. The search for novel drug candidates is a priority goal for cancer therapy. However, the emergence of drug resistance reduces the effectiveness of new medications. The ATP binding cassette (ABC) family of proteins are efflux pumps that transport various structurally unrelated and potentially dangerous substances out of the cells. These transporters have evolved as a complex cellular defense system, for the recognition and removal of toxic agents entering the cells from their environment. Several of the ABC transporters are related to chemoresistance in cancer therapy, as the rapidly dividing malignant cells use them to protect themselves from medical interventions. Here we review the members of the ABC transporter families responsible for the multidrug resistance in anticancer therapy.
癌症是发达国家主要的死亡原因之一。寻找新型候选药物是癌症治疗的首要目标。然而,耐药性的出现降低了新药物的疗效。ATP结合盒(ABC)蛋白家族是外排泵,可将各种结构不相关且可能具有危险性的物质转运出细胞。这些转运蛋白已演变成一个复杂的细胞防御系统,用于识别和清除从周围环境进入细胞的有毒物质。一些ABC转运蛋白与癌症治疗中的化疗耐药性有关,因为快速分裂的恶性细胞利用它们来保护自己免受医学干预。在此,我们综述了在抗癌治疗中导致多药耐药的ABC转运蛋白家族成员。